| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | DNA |
| Clinical data | |
| Other names | GX-19N |
| Routes of administration | Intramuscular |
| Identifiers | |
| DrugBank | |
| Part ofa series on the |
| COVID-19 pandemic |
|---|
 |
|
Medical response |
|
.svg) COVID-19 portal |
GX-19 is aCOVID-19 vaccine candidate developed by Genexine consortium.[1][2][3][4]
It is aDNA-based vaccine that encodes the SARS-CoV-2spike protein.[5]
.png) | This article about COVID-19 vaccines is astub. You can help Wikipedia byexpanding it. |
 | This article aboutvaccines orvaccination is astub. You can help Wikipedia byexpanding it. |
